Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 18.75% is 49% below its 5-year average of 36.64%, near the low end of its 5-year range (1.55%–71.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 66.17% below its 12-month average of 55.42%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 18.75%.
DEBT TO ASSETS RATIO
18.75%
DEBT TO ASSETS RATIO AVG TTM
55.42%
DEBT TO ASSETS RATIO AVG 3Y
58.93%
DEBT TO ASSETS RATIO AVG 5Y
36.64%
DEBT TO ASSETS RATIO AVG 10Y
19.10%
DEBT TO ASSETS RATIO AVG 15Y
1.31%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-66.17%
CURRENT VS 3Y AVG
-68.18%
CURRENT VS 5Y AVG
-48.83%
CURRENT VS 10Y AVG
-1.87%
CURRENT VS 15Y AVG
+1336.26%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
+17754.86%
vs the sector median at left
Enanta Pharmaceuticals, Inc.
Market Cap
$365.95M
Debt to Assets Ratio
18.75%
TTM Avg
55.42%
3Y Avg
58.93%
5Y Avg
36.64%
Market Cap
$360.92M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$359.16M
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$376.01M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$380.88M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.63M
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$339.93M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals, Inc. (ENTA) | $365.95M | 18.75% | 55.42% | 58.93% | 36.64% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $360.92M | 0.00% | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $359.16M | 0.38% | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | 0.25% | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $352.29M | 0.24% | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $380.88M | 0.15% | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $348.85M | 1.19% | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $348.63M | 0.74% | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $339.93M | 0.03% | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $334.26M | 0.10% | N/A | N/A | N/A |
Debt/Assets
18.7%
Debt/Equity
0.55
Current Ratio
3.76
Interest Coverage
-11.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 18.75% |
| 2026-03-31 | 59.30% |
| 2025-12-31 | 58.63% |
| 2025-09-30 | 71.62% |
| 2025-06-30 | 68.80% |
| 2025-03-31 | 66.92% |
| 2024-12-31 | 63.47% |
| 2024-09-30 | 60.02% |
| 2024-06-30 | 56.71% |
| 2024-03-31 | 55.58% |
| 2023-12-31 | 51.34% |
| 2023-09-30 | 48.12% |
| 2023-06-30 | 46.61% |
| 2023-03-31 | 9.01% |
| 2022-12-31 | 7.70% |
| 2022-09-30 | 7.01% |
| 2022-06-30 | 6.83% |
| 2022-03-31 | 4.83% |
| 2021-12-31 | 4.75% |
| 2021-09-30 | 1.55% |
| 2021-06-30 | 1.81% |
| 2021-03-31 | 1.99% |
| 2020-12-31 | 2.12% |
| 2020-09-30 | 1.95% |
| 2020-06-30 | 2.04% |
| 2020-03-31 | 2.09% |
| 2019-12-31 | 2.10% |
| 2019-09-30 | 0.04% |
| 2019-06-30 | 0.05% |
| 2019-03-31 | 0.05% |
| 2018-12-31 | 0.06% |
| 2018-09-30 | 0.07% |
| 2018-06-30 | 0.08% |
| 2018-03-31 | 0.10% |
| 2017-12-31 | 0.11% |
| 2017-09-30 | 0.14% |
| 2017-06-30 | 0.17% |
| 2017-03-31 | 0.18% |
| 2016-12-31 | 0.18% |
| 2016-09-30 | 0.19% |
| 2016-06-30 | 0.19% |
| 2016-03-31 | 0.20% |
| 2015-12-31 | 0.21% |
| 2015-09-30 | 0.24% |
| 2015-06-30 | 0.07% |
| 2015-03-31 | 0.08% |
| 2014-12-31 | 0.09% |
| 2014-09-30 | 0.13% |
| 2014-06-30 | 0.13% |
| 2014-03-31 | 0.18% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2011-09-30 | 0.00% |
